Haichen Pharmaceutical announced that Cao Yuping, the controlling shareholder and actual controller, has released all 40,000,000 shares, accounting for 7.92% of its shares and 3.33% of the company's total share capital. The pledge commencement date is December 2, 2024, and the cancellation date is January 5, 2026; it currently holds 5049,1306 shares, accounting for 42.08% of the company's total share capital, with a corresponding pledge balance of 0 shares.

Haichen Pharmaceutical announced that Cao Yuping, the controlling shareholder and actual controller, has released all 40,000,000 shares, accounting for 7.92% of its shares and 3.33% of the company's total share capital. The pledge commencement date is December 2, 2024, and the cancellation date is January 5, 2026; it currently holds 5049,1306 shares, accounting for 42.08% of the company's total share capital, with a corresponding pledge balance of 0 shares.